Filing Details
- Accession Number:
- 0001140361-13-025991
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-06-21 14:16:23
- Reporting Period:
- 2013-06-21
- Filing Date:
- 2013-06-21
- Accepted Time:
- 2013-06-21 14:16:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 730272 | Repligen Corp | RGEN | Biological Products, (No Disgnostic Substances) (2836) | 042729386 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1261506 | A Karen Dawes | C/O Repligen Corporation 41 Seyon Street, Bldg 1, Ste 100 Waltham MA 02453 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-06-21 | 1,000 | $7.70 | 33,880 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
